Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Study sponsor: Verrica Pharmaceuticals Inc. · VRCA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-04-15Actual
Enrollment · participants92Actual
Source updated2025-06-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.